Organon & Co.: Osteoporosis trials

The registry lists 18 Osteoporosis studies with Organon & Co. as lead sponsor. 0 are open to participants now and 7 have results posted.

Phase 1 3Phase 3 12Phase 4 1No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Study of MK-217A/Alendronate Sodium 70-mg/Vitamin D3 5600 IU Combination Tablet (MK-0217A-329)CompletedNCT01437111Phase 3Results posted
• A Study to Evaluate Alendronate Sodium /Vitamin D3 Combination Tablets(FOSAMAX PLUS) Versus Calcitriol in the Treatment of Osteoporosis in Postmenopausal Women in China (MK-0217A-264)CompletedNCT01350934Phase 4Results posted
• Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)CompletedNCT01077817Results posted
• FOSAMAX PLUS and FOSAMAX PLUS D Re-examination Study (0217A-267)CompletedNCT01065779Results posted
• A Study of the Bioequivalence of 70 mg Alendronate and 70 mg Alendronate in Combination With 2800 IU Vitamin DCompletedNCT00806416Phase 1Results posted
• A Study of the Bioequivalence of 70-mg Alendronate and 70-mg Alendronate in Combination With 5600 IU Vitamin D (MK0217A-253)CompletedNCT00803790Phase 1Results posted
• A Study to Test the Effect of MK0217A on Vitamin D Inadequacy in Postmenopausal Women With Osteoporosis (0217A-262)CompletedNCT00692913Phase 3Results posted
• 4-Week Study to Assess the Effect of Alendronate and Vitamin D3 Once Weekly on Fractional Calcium Absorption in Postmenopausal Osteoporotic Women (0217A-230)CompletedNCT00641771Phase 1
• Trial to Evaluate Tibolone in the Treatment of Osteoporosis (P06468)CompletedNCT00519857Phase 3
• A Research Study to Evaluate the Safety and Effectiveness of MK0217 to Prevent and Treat Bone Loss (0217-193)(COMPLETED)CompletedNCT00480766Phase 3
• FLEX - Long-term Extension of FIT (Fracture Intervention Trial)(0217-051)CompletedNCT00398931Phase 3
• A Study to Compare the Efficacy of Alendronate With and Without Calcium or Calcium Alone In the Treatment of Osteoporosis in Postmenopausal Women (0217-088)(COMPLETED)CompletedNCT00398606Phase 3
• A Comparison Study With Alendronate and Raloxifene in Postmenopausal Women With Osteoporosis (0217-189)CompletedNCT00389740Phase 3
• A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)CompletedNCT00092066Phase 3
• Study of Investigational Drug in Osteoporosis (MK-0217-908)CompletedNCT00092053Phase 3
• A Study and 12 Month Extension to Evaluate Two Investigational Drugs in Postmenopausal Women With Osteoporosis (MK-0217-907)CompletedNCT00092040Phase 3
• A Study to Evaluate the Safety and Tolerability of MK0217 in Women (0217-219)CompletedNCT00092027Phase 3
• A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211)CompletedNCT00092014Phase 3